Two major drugmakers recently announced additional states that will no longer be subject to their 340B contract pharmacy restrictions following [...] …
Category: Pharma Industry
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...] …
A federal district judge today upheld the Department of Health and Human Services’ (HHS) authority to preapprove 340B rebate models, [...] …
In their second emergency motion this month, a group of drugmakers is urging a federal appeals court to reject a [...] …
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. this week defended President Donald Trump’s Fiscal Year 2026 proposed [...] …
Drugmakers Amgen, GSK, Merck and Sobi recently announced they are exempting more states from their 340B contract pharmacy restrictions amid [...] …
Maine recently became the 20th state to enact a 340B contract pharmacy access law as part of a sweeping budget [...] …
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...] …
Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...] …
President Donald Trump’s recent executive order directing federal agencies to pursue “most favored nation” (MFN) pricing for prescription drugs could [...] …